If you picture a world where medicine heals and uplifts through both innovation and heart, you can see the vision of Dr. Karine Sargsyan—a vision she is actively bringing to life. As a physician, geneticist, futurist, and bestselling author, Dr. Sargsyan is redefining health and longevity with passion and brilliance.
Her journey is as inspiring as her mission. Born in Armenia, she overcame both dyslexia and cancer to earn a medical degree in pediatrics, a doctorate in genetics, and a master’s in psychology. That resilience now fuels her global impact.
Dr. Sargsyan serves as Scientific Director of the Onco Biobank at Cedars-Sinai, where she leads translational oncology research focused on cancer and healthy aging. Under her leadership, the biobank has become one of the most widely used clinical collections. She is also the Co-Principal Investigator of the Molecular Twin Initiative, which applies artificial intelligence and machine learning to biomedical science in order to foster groundbreaking inventions and personalize cancer treatments.
Dr. Sargsyan serves as Scientific Director of the Onco Biobank at Cedars-Sinai, where she leads translational oncology research focused on cancer and healthy aging. Under her leadership, the biobank has become one of the most widely used clinical collections. She is also the Co-Principal Investigator of the Molecular Twin Initiative, which applies artificial intelligence and machine learning to biomedical science in order to foster groundbreaking inventions and personalize cancer treatments.
At the international level, she chairs the Advisory Board of CMF, a Nobel-winning institute, collaborating with two Nobel laureates and the rectors of major European universities. In parallel, she heads the Department of Digital Medicine and Artificial Intelligence at Yerevan State Medical University, where she mentors the next generation of innovators.
